Ashwagandha: The Complete Scientific Guide to Benefits, Dosage and Safety

Ashwagandha is one of the most researched adaptogenic herbs in the world, and also one of the most misunderstood. Walk into any supplement shop and you will see it promoted for stress, sleep, muscle, hormones and focus. Some of those promises are backed by well-designed human trials. Others rest on small studies, animal work or tradition alone. And in recent years, a handful of liver-injury reports have reminded everyone that "natural" does not mean "risk-free."

If you have ever wondered what the herb actually contains, what the evidence truly shows, how much people take in studies, who should avoid it, and how to spot a poor-quality product, this guide is written for you. It follows the scientific literature section by section, separates strong evidence from weak evidence, and points you to the primary studies so you can verify every important claim yourself.

Read on and you will move from the basic identity of the plant, through its chemistry and mechanisms, to the clinical trials and the practical details of using it wisely.

---

Ashwagandha Quick Facts: Executive Summary

Attention: the short version. Here is the whole story in a few lines before we go deep.

• What it is: a root-derived botanical from Withania somnifera, a small shrub in the nightshade family, used for roughly three thousand years in Ayurvedic medicine as a rejuvenating tonic (rasayana).
• Main active constituents: a family of steroidal lactones called withanolides (such as withanolide A, withanoside IV and withaferin A), plus alkaloids, saponins and sitoindosides.
• Best-supported uses: reducing perceived stress and anxiety, improving sleep quality (especially in people with sleep complaints), and modest gains in strength and recovery when combined with resistance training.
• Emerging, less certain areas: testosterone and sperm parameters, thyroid function, cognition, sexual function and blood sugar.
• Typical study doses: 250 to 600 mg per day of a standardized root extract, most often 300 mg twice daily, for 8 to 12 weeks.
• Safety headline: generally well tolerated in short trials, but rare cases of clinically apparent liver injury have been reported. People with liver disease, thyroid disorders, autoimmune conditions, pregnancy or upcoming surgery need medical guidance first.
• Quality headline: potency, plant part (root versus leaf) and contamination vary widely between products, so third-party testing matters.
• Regulatory status: sold as a dietary supplement in the United States and many other countries, but restricted or under review in a few jurisdictions.

---

What Is Ashwagandha? Ingredient Definition and Identity

In plain terms, this ingredient is the dried root (and sometimes leaf) of Withania somnifera, prepared as a powder, aqueous or hydroalcoholic extract, capsule, tablet, tincture, gummy or functional-food additive. The name comes from Sanskrit: ashva means horse and gandha means smell, a reference to the strong, earthy, horse-like odor of fresh roots. A second reading says the name hints at the vigor and stamina a horse symbolizes, which is exactly what traditional healers hoped the root would confer.

Identity matters because the word on a label can mean very different things. A product might contain:

1. Plain root powder, ground and encapsulated with no concentration of actives.
2. A standardized root extract, in which a defined percentage of withanolides is guaranteed.
3. A leaf-containing extract, which has a different chemical profile and, in some cases, a higher proportion of withaferin A.
4. A root-and-leaf blend, combining both profiles.
5. A fermented or processed preparation, used mainly in traditional formulations.

Because clinical trials are run on specific extracts, results from one preparation cannot be freely transferred to another. A trial using a 5 percent withanolide root extract tells you something about that extract, not about every bottle on a shelf. Keeping this identity problem in mind will help you read the rest of this guide critically.

The herb is classed in Ayurveda as a rasayana (rejuvenative), balya (strength-promoting) and medhya (supportive of mental faculties). In modern language, it is classed as an adaptogen: a substance proposed to help the body maintain balance under physical, chemical or psychological stress. The adaptogen concept itself remains debated among scientists, and we will return to that point when discussing mechanisms and research gaps.

---

Botanical and Chemical Classification of Withania somnifera

Botanical taxonomy

Withania somnifera belongs to the following hierarchy:

• Kingdom: Plantae
• Clade: Angiosperms, Eudicots, Asterids
• Order: Solanales
• Family: Solanaceae
• Genus: Withania
• Species: Withania somnifera (L.) Dunal

The genus contains roughly ten to twenty recognized species depending on the taxonomic authority. Related species such as Withania coagulans (used in some traditional preparations for its milk-clotting enzymes) are sometimes confused with the main species, which is one source of labeling errors. The species name somnifera is Latin for sleep-inducing, which reflects its long-standing reputation as a calming herb.

The plant is a woody, branching, evergreen shrub that typically grows 30 to 150 centimeters tall. It carries small, greenish-yellow bell-shaped flowers, and its fruits are orange-red berries enclosed in a papery husk, which explains the English nickname "winter cherry." The tuberous roots, light brown outside and creamy white inside, are the traditional medicinal part.

Chemotypes

One of the most important facts for researchers is that the plant exists as distinct chemotypes. Plants from different geographies or genetic lines produce different withanolide patterns. Studies have described chemotypes dominated by withaferin A, others dominated by withanolide D, and others with different ratios. The Indian-grown plant used in most commercial root extracts tends to have a relatively low withaferin A content in the root and a higher proportion of other withanolides, while leaves often contain far more withaferin A. This is why plant part and origin appear on quality specifications.

Chemical classification

From a chemistry standpoint, the herb is a multi-component natural product matrix. Its principal classes are:

• Steroidal lactones (withanolides): C28 ergostane-type compounds with a lactone ring, the signature class.
• Alkaloids: including withanine, somniferine, tropine and anaferine.
• Saponins and glycosides: including sitoindosides VII to X and withanosides.
• Flavonoids and phenolics: minor but potentially contributing antioxidant activity.
• Carbohydrates, fatty acids, amino acids and minerals: including notable iron content.

This chemical diversity is the reason scientists prefer the term "full-spectrum extract" to describe preparations that preserve the whole profile rather than isolating a single compound.

---

Origin, Cultivation and Sourcing of Ashwagandha

Where it grows

The plant is native to the drier regions of India, the Middle East and parts of Africa. India is the largest commercial producer, with cultivation concentrated in Madhya Pradesh (notably Mandsaur and Neemuch), Rajasthan and Gujarat, along with smaller areas in Maharashtra, Uttar Pradesh and the southern states. Wild or semi-wild populations also occur around the Mediterranean, in Yemen and across parts of Africa. Cultivation outside South Asia, including trial plantations in several other countries, has grown as global demand has risen.

Growing conditions

The crop prefers semi-arid conditions with sandy loam or light red soil, good drainage and moderate rainfall. It is typically sown at the start of the monsoon (June to August) and harvested roughly 150 to 180 days later, around January to March when leaves begin to dry and berries turn red. Because it tolerates poor soils and relatively low rainfall, it is a useful cash crop for smallholder farmers, and cultivation has been actively promoted in several Indian states.

Harvest and post-harvest handling

After harvest, plants are uprooted, roots are separated, washed, cut into short pieces and dried in the sun or in controlled dryers. The way roots are dried, stored and graded influences moisture, microbial load and, to some extent, withanolide stability. Poor drying raises the risk of mold and aflatoxin contamination, which is one reason quality standards focus on moisture content and microbiology.

Sustainability and supply chain

Several features of the supply chain deserve attention for anyone sourcing the ingredient:

• Wild harvesting pressure can threaten natural populations, so cultivated material is preferred.
• Regional chemotype variation means that a stable, traceable supply is essential for consistent standardization.
• Traceability from farm to extract helps prevent substitution and adulteration.
• Organic and sustainable certifications exist, though they certify farming practice and not potency.

---

History and Traditional Use in Ayurveda

Ancient texts

References to this root appear in classical Ayurvedic literature, including the Charaka Samhita and Sushruta Samhita, as well as later materia medica. Traditional practitioners described it as a tonic for debility, emaciation, "weakness of the nerves," sleeplessness, joint pain and aging-related decline. Its place among the rasayana group meant it was prescribed to promote longevity, resilience and vitality, particularly in the convalescent and the elderly.

Traditional preparations

Classical methods included:

• Churna: dried root powder, often taken with milk, ghee or honey.
• Kwatha: decoction made by boiling root in water.
• Ghrita and taila: medicated ghee or oil preparations for oral or topical use.
• Lehya: thickened herbal pastes.
• Compound formulas: combinations with other herbs such as shatavari, bala or guduchi.

Traditional dosing was individualized by constitution (prakriti), season and the condition treated. The standard modern shorthand of a few grams of powder per day reflects this older practice, though it differs greatly from the milligram doses of concentrated extracts used in current trials.

Beyond India

Traditional use extended into Unani medicine and into folk medicine across the Middle East and parts of Africa, where leaves and roots were applied for inflammation, skin conditions and fever. Western awareness grew in the twentieth century through pharmacological investigations in India, and global popularity accelerated in the 2000s as standardized extracts and clinical trials appeared.

Lessons from tradition

Tradition is a source of hypotheses, not proof. The long record of use suggests the root is reasonably tolerated at traditional doses, and it pointed researchers toward stress, sleep, vitality and cognition as study targets. At the same time, traditional claims about aging, fertility or disease cure cannot substitute for controlled trials, and the history says very little about the risk of rare adverse events, which only show up in large-scale pharmacovigilance.

---

Modern Nutraceutical Use of Ashwagandha

From tonic to global supplement

Over the last two decades, this botanical moved from specialist Ayurvedic shops to mainstream supplement aisles worldwide. It now appears in capsules, powders, gummies, tinctures, teas, sleep blends, stress formulas, sports nutrition products, "mood" beverages and even pet products. Market analysts have repeatedly listed it among the fastest-growing botanical ingredients in the adaptogen category.

Common marketing positions

Brands usually position it around a handful of themes:

1. Stress and anxiety support, the most common and best-supported claim.
2. Sleep quality and relaxation.
3. Sports performance, strength and recovery.
4. Men's health and testosterone support.
5. Women's wellness and sexual function.
6. Cognitive support, memory and focus.
7. Thyroid and metabolic support.
8. Healthy aging and general vitality.

Where the science and marketing diverge

Marketing often generalizes from a few positive trials to a broad list of benefits. In practice:

• Claims around stress, anxiety and sleep have multiple randomized trials and some meta-analyses behind them.
• Claims about muscle and strength have smaller but increasingly consistent support.
• Claims about testosterone, fertility, thyroid and cognition rest on fewer, smaller or heterogeneous studies.
• Claims about cancer, diabetes or neurodegeneration treatment are mostly preclinical and must not be read as treatment advice.

Role in formulations

Formulators combine it with magnesium, L-theanine, melatonin, rhodiola, lemon balm, creatine or protein products. Combination products complicate interpretation because any benefit cannot be credited to one ingredient. When evaluating a product, check whether the quantity of the botanical itself matches what trials actually used.

---

Chemical Composition of Ashwagandha Root and Leaf

Root composition

The dried root is mostly carbohydrate and fiber, with smaller fractions of protein, fatty acids, minerals and secondary metabolites. The nutritionally minor but pharmacologically interesting portion includes:

• Withanolides: typically around 0.3 to 0.5 percent of dry root in many raw materials, concentrated to higher percentages in extracts.
• Alkaloids: present in low amounts, with total alkaloid content generally well under one percent.
• Saponins and sitoindosides: acylated steryl glucosides and related compounds.
• Amino acids and proteins: a modest protein fraction.
• Minerals: notable iron, plus potassium, calcium and trace elements.
• Starch and sugars: a large share of the bulk material.

Leaf composition

Leaves contain higher levels of some withanolides, particularly withaferin A, along with flavonoids, chlorogenic-type phenolics and additional glycosides. Because of this profile, leaf-containing products are not equivalent to root products in pharmacology or safety. Research has also noted that some withanolides have cytotoxic properties in laboratory systems, which is a reason many manufacturers restrict withaferin A content in finished products.

Variability

Composition is not fixed. It shifts with:

• Genotype and chemotype
• Soil, climate and altitude
• Harvest age and time of year
• Drying and storage conditions
• Plant part and extraction method

This variability is the core reason modern analytical standards and chromatographic fingerprinting are used to specify products, and why two products labeled with the same botanical name can behave differently.

---

Key Active Compounds: Withanolides and Beyond

Withanolides

Withanolides are the signature compounds, with several hundred structures described across the genus. The ones most often discussed in the literature are:

• Withaferin A: a well-studied withanolide with potent activity in cell and animal models, including anti-inflammatory and anti-proliferative effects. It is more abundant in leaves and is also the compound most associated with concerns about cytotoxicity at high exposure.
• Withanolide A: studied for neuronal effects, including promotion of neurite outgrowth in cell models.
• Withanolide D: studied for anti-proliferative and immune-modulating activity.
• Withanone: a major component in some chemotypes, studied for stress-protective effects in cells.
• Withanosides (for example IV and V): glycosylated forms studied in neuroprotection models.

Alkaloids

Compounds such as withanine, somniferine, anaferine and isopelletierine contribute to the plant's chemical profile. Their individual pharmacology is less well characterized than that of the withanolides. Some researchers have suggested they might contribute to the calming or sedative reputation of the herb, but human evidence isolating their effects is lacking.

Sitoindosides and other glycosides

Sitoindosides VII to X, some acylated with fatty acids, were among the early compounds linked to antistress and immunomodulatory activity in rodent experiments in the 1980s and 1990s. They remain part of the "full-spectrum" argument, though modern studies emphasize the withanolides as marker compounds.

Other constituents

• Flavonoids and phenolic acids add antioxidant potential in vitro.
• Fatty acids and sterols (such as beta-sitosterol and stigmasterol) are present in small amounts.
• Iron content is nutritionally interesting but unlikely to be clinically significant at supplemental doses.

Which compounds actually do the work?

This is an honest scientific gap. Most mechanistic experiments use isolated withanolides or crude extracts at concentrations that may not be reached in human blood after oral dosing. The assumption that withanolides are the active principle is reasonable but not fully proven for each human outcome. Multi-compound synergy remains plausible, and it is one reason many researchers prefer testing whole standardized extracts rather than single molecules.

---

Extraction and Processing Methods

From raw root to ingredient

Commercial processing generally follows these stages:

1. Raw material receipt and identification: botanical authentication and screening for foreign matter.
2. Cleaning, cutting and drying: reducing moisture and microbial load.
3. Milling: producing a powder for direct use or for extraction.
4. Extraction: using water, ethanol, a water-ethanol mixture, or in some cases supercritical carbon dioxide.
5. Concentration and filtration: removing solvent and insoluble matter.
6. Drying: spray drying or vacuum drying to a powder.
7. Standardization and blending: adjusting to a target marker content.
8. Testing, packaging and release.

Extraction solvents and what they pull out

• Water extracts capture more polar, glycosylated compounds such as withanosides.
• Hydroalcoholic extracts capture a broader range of withanolides, both free and glycosylated.
• Supercritical CO2 extraction targets less polar compounds and is solvent-free in the final product, though less common for this root.
• Enzymatic or fermentation-assisted approaches are sometimes used to alter glycoside patterns, though published human data on these are limited.

Branded and proprietary methods

Several branded extracts are widely discussed in clinical literature. They differ in plant part, solvent, withanolide specification and whether they are "full-spectrum." Common examples seen in published trials include a root-only extract standardized to roughly 5 percent withanolides, a root-and-leaf extract with a higher withanolide glycoside content and a limit on withaferin A, and a highly concentrated root extract standardized to around 35 percent withanolide glycosides. Because these differ, the clinical results from one cannot be automatically extended to the others.

Processing and stability

Heat, light, moisture and oxygen can degrade some withanolides. Good manufacturers control drying temperature, store raw material cool and dry, and monitor stability in finished goods across shelf life. Residual solvent testing is a necessary part of release for solvent-based extracts.

---

Standardization and Potency of Ashwagandha Extracts

What standardization means

Standardization is the practice of ensuring a product delivers a consistent, defined amount of one or more markers, so that a dose in one batch is comparable to a dose in another. For this botanical, the usual markers are total withanolides, withanolide glycosides, and sometimes specific compounds such as withaferin A or withanolide A.

Common specifications

• Plain root powder: often not standardized, or loosely specified at 0.3 to 1 percent withanolides.
• Root extracts: commonly 2.5 to 10 percent total withanolides, sometimes higher.
• Highly concentrated extracts: up to 30 to 35 percent withanolide glycosides.
• Leaf-containing extracts: specified with limits on withaferin A to keep it below a defined threshold.

Analytical methods

Potency is verified by laboratory techniques, most often:

• HPLC (high-performance liquid chromatography) with UV or mass-spectrometry detection.
• HPTLC (high-performance thin-layer chromatography) for fingerprinting.
• LC-MS/MS for precise identification and quantification of individual withanolides.

Why potency matters when comparing doses

A 600 mg capsule of a 5 percent extract delivers around 30 mg of withanolides, while 600 mg of a 35 percent extract would deliver around 210 mg. Reading only the "mg of ashwagandha" on a label can therefore be misleading. The meaningful questions are: what extract, what plant part, what marker percentage, and what dose was used in the clinical trial the product claims to rely on?

The percentage trap

Higher percentage is not automatically better. Some manufacturers push marker percentages high using methods that narrow the chemical profile, and a narrow profile may not replicate trial outcomes obtained with a full-spectrum preparation. The safest approach is to choose a product whose extract and dose match a published clinical protocol.

---

Mechanisms of Action: How Ashwagandha May Work

Most mechanistic evidence comes from cell and animal studies, with limited direct human mechanistic data. The leading hypotheses are summarized below.

1. Modulation of the stress axis (HPA axis)

The best-supported mechanism in humans is a reduction in serum cortisol. Several randomized trials report lower morning cortisol in stressed adults after supplementation compared with placebo. Animal studies suggest regulation of the hypothalamic-pituitary-adrenal axis, including effects on corticotropin-releasing factor signaling. This fits the adaptogen concept but does not prove that cortisol lowering alone explains the improvement in stress scores.

2. GABAergic activity

Laboratory work has shown that certain withanolides and extract fractions can interact with GABA-A receptor signaling, the main inhibitory neurotransmitter system targeted by many anxiolytic and sleep-promoting drugs. A GABA-mimetic action would match the calming and sleep-supportive reputation, but receptor-level human evidence is still thin.

3. Anti-inflammatory and antioxidant effects

Withanolides, withaferin A in particular, can inhibit NF-kB signaling and reduce inflammatory cytokines in cell models. Some human trials have reported lower C-reactive protein or improved antioxidant enzyme markers, but these findings are inconsistent and often secondary outcomes.

4. Neuroprotective and neurotrophic signaling

In cell and rodent models, withanolide A and withanosides promoted neurite outgrowth, reduced amyloid-related toxicity and modulated synaptic signaling. These results motivate cognitive studies, though translating them to humans requires larger trials with careful dose and bioavailability design.

5. Immunomodulation

Both immune-stimulating and immune-dampening effects have been reported in animal and some human experiments, depending on context and dose. This dual behavior is why people with autoimmune disease or those on immunosuppressants are cautioned to seek advice.

6. Endocrine effects

Some trials report changes in DHEA-S, testosterone and thyroid hormones. The mechanism is not fully established, and indirect effects through stress reduction may contribute. Because thyroid hormones can rise, caution applies in people with thyroid disease.

7. Heat shock protein and cellular stress responses

Laboratory work suggests induction of cellular stress-response pathways and modulation of proteins involved in protein folding, which may underlie the "adaptogenic" label at the cell level.

A balanced interpretation

The mechanism list is long, and that itself is a caution. Compounds that seem to act on many pathways in a petri dish do not always do so at the low concentrations reached in the human bloodstream. Mechanistic studies are best read as plausible explanations, not confirmed ones.

---

Pharmacokinetics

What is known

Human pharmacokinetic data for individual withanolides are limited compared with the volume of clinical outcome research. Existing information comes from a mix of rodent studies, a small number of human studies, and in vitro metabolism work.

Absorption

After oral dosing, withanolides appear to be absorbed, though extent varies by compound, form and extraction method. Animal studies show measurable plasma levels of withaferin A and withanolide A after oral administration of root extracts, with relatively low absolute oral exposure for some compounds.

Distribution

Rodent data indicate that some withanolides can reach tissues, and certain compounds have been detected in brain tissue in animal studies, which supports interest in neuroactive effects. Human tissue distribution data are essentially absent.

Metabolism

Withanolides can undergo glycoside hydrolysis, conjugation and phase I metabolism. In vitro studies suggest possible interaction with some cytochrome P450 enzymes and drug transporters, though the clinical relevance of these findings is not established. Gut microbiota may play a role in converting glycosides to aglycones, which could partly explain inter-individual variation.

Excretion

Elimination appears to occur via both urine and feces, though reliable human mass-balance data are lacking.

Half-life and dosing frequency

Clinical protocols commonly use twice-daily dosing, which suggests investigators assume a fairly short effective window, but this has been driven largely by convention and trial design rather than by definitive human half-life measurements for all active constituents.

Why this matters

Without robust human pharmacokinetics, several practical questions remain open: the ideal timing relative to meals, whether a once-daily dose is as effective as split dosing, how much individual compounds accumulate with repeated use, and how age, liver function or genetics change exposure.

---

Bioavailability

The central challenge

Many withanolides are lipophilic, and glycosylated forms may be poorly absorbed intact. As a result, oral bioavailability of individual compounds is thought to be modest, and it varies with the formulation.

Strategies used to improve absorption

Manufacturers and researchers have explored several approaches:

• Co-formulation with piperine (black pepper extract), proposed to inhibit metabolic enzymes and increase exposure, though evidence for this specific herb is limited.
• Lipid-based delivery systems, including phospholipid complexes and self-emulsifying systems, designed to improve solubilization of lipophilic withanolides.
• Nanoparticle and nanoemulsion formats, mostly at an experimental stage.
• Fermentation or enzyme treatment to convert glycosides into more absorbable forms.
• Taking the dose with food or a fat-containing meal, a practical approach consistent with the lipophilic nature of many constituents, though not rigorously tested for this botanical.

Evidence quality

Most bioavailability claims on product labels are based on in vitro tests, animal data or manufacturer-sponsored studies with small samples. Independent, well-powered human crossover studies are scarce. A product claiming several-fold higher absorption deserves scrutiny: ask what compound was measured, in what population and whether the improvement translated into better clinical outcomes.

Practical takeaway

Since clinical benefits have been shown with ordinary standardized extracts, bioavailability-enhanced products are not necessarily required. If you choose one, verify that the specific formulation has its own human data rather than relying on general claims.

---

Preclinical Evidence Summary

Preclinical research (cells and animals) covers a very wide landscape. It is valuable for generating hypotheses and understanding mechanisms, but it is the lowest tier of evidence for human benefit.

Stress, anxiety and mood

Rodent studies repeatedly show that root extracts reduce stress-induced biochemical changes, lower corticosterone, and produce anxiolytic-like behavior in standard tests such as the elevated plus maze. Some effects were comparable to reference drugs in these models.

Sleep

Animal studies, including work on specific leaf-derived compounds, suggest increased non-REM sleep and sleep-promoting activity, which links to the herb's species name and traditional use.

Neuroprotection and cognition

Models of Alzheimer's, Parkinson's and other neurodegenerative conditions show reduced oxidative damage, improved memory performance and reduced amyloid-related toxicity with various extracts and isolated withanolides.

Inflammation and immunity

Cell and animal studies show suppression of inflammatory mediators, modulation of T-cell and macrophage activity, and reduced arthritis-like symptoms in rodent models.

Cancer research

Withaferin A and some other withanolides inhibit proliferation, induce apoptosis and reduce metastasis-related signaling in multiple cancer cell lines and animal xenograft models. This is an area of real scientific interest, but it is nowhere near evidence that the supplement treats or prevents cancer in people. Concentrations used in cell experiments often far exceed what is achievable through oral supplementation.

Metabolic and cardiovascular models

Studies in diabetic and obese rodents report improvements in glucose handling, lipid levels and oxidative stress markers. Human data, discussed later, are far more limited.

Reproductive and endocrine models

Rodent studies suggest effects on testosterone, sperm parameters and thyroid hormones, with mixed directions depending on dose and condition.

Toxicology

Standard toxicology in animals suggests low acute toxicity at typical doses, though high doses of certain withanolide-rich fractions have caused adverse effects in some experiments, and withaferin A can be cytotoxic in cell systems.

How to read this evidence

Preclinical findings are consistent across many labs, which is encouraging, but animals are not people. Doses are often high, routes of administration may differ, and publication bias can inflate positive results. The right conclusion is "promising hypothesis," not "proven benefit."

---

Human Clinical Evidence on Ashwagandha Benefits

This section is the heart of the guide. It summarizes the randomized controlled trials (RCTs) and meta-analyses that matter most, outcome by outcome. Study sizes are usually modest (often 40 to 130 participants), most trials last 8 to 12 weeks, and many were funded by extract manufacturers. Keep those limits in mind while reading.

Stress and anxiety

A frequently cited eight-week RCT in adults with chronic stress, using 300 mg twice daily of a root extract, reported significantly greater reductions in perceived stress scale scores and serum cortisol than placebo (Chandrasekhar et al., 2012). Further trials, using different extracts and doses from 240 to 600 mg per day, reported reductions in anxiety scales and stress-related biomarkers. Systematic reviews of anxiety and stress studies generally conclude that the results are favorable but caution about small samples, short duration, heterogeneity of extracts and risk of bias (Pratte et al., 2014; Akhgarjand and colleagues, 2022).

Plain reading: among all ashwagandha benefits, reduced perceived stress and anxiety has the most consistent human support.

Sleep

A meta-analysis of randomized trials found a small but statistically significant improvement in overall sleep with the herb compared with placebo, with larger effects in people diagnosed with insomnia, at doses of 600 mg per day or more, and over eight weeks or longer (Cheah et al., 2021). Individual trials in adults with sleep complaints have reported improvements in sleep onset latency, sleep efficiency and perceived sleep quality (for example Langade et al., 2019).

Plain reading: helpful for some people with sleep difficulties, but effect sizes are modest, and healthy sleepers may see little change.

Muscle strength and exercise performance

In young men performing resistance training, 600 mg per day of a root extract for eight weeks was associated with larger gains in muscle strength and size, and lower exercise-induced muscle damage markers, than placebo (Wankhede et al., 2015). A systematic review and Bayesian meta-analysis reported small to moderate improvements in maximal oxygen uptake and strength measures in healthy individuals, with considerable heterogeneity (Bonilla et al., 2021).

Plain reading: plausible, modest benefit when combined with proper training and nutrition; not a substitute for either.

Testosterone, DHEA-S and male reproductive health

A trial in men aged roughly 40 to 70 with mild fatigue reported higher DHEA-S and a modest rise in testosterone with a high-concentration root extract versus placebo, along with improvements in some mood and sexual-function measures (Lopresti et al., 2019). Studies in men with low sperm counts or stress-related infertility reported improvements in sperm concentration and motility, though these were small and often not well controlled (Ambiye et al., 2013).

Plain reading: interesting but preliminary; not an established treatment for low testosterone or male infertility.

Women's sexual function

A small randomized trial reported improvements in several domains of sexual function in women with sexual dysfunction who took an extract compared with placebo (Dongre et al., 2015). The evidence base is limited.

Thyroid function

A small randomized trial in people with subclinical hypothyroidism reported improvements in thyroid-stimulating hormone and thyroid hormone levels at 600 mg per day for eight weeks (Sharma et al., 2018). Because the herb can also increase thyroid hormones in healthy people, this is both a possible benefit and a possible risk. Self-treating thyroid disease with it is not advised.

Cognition and memory

Systematic reviews of trials in healthy adults, older adults with mild cognitive impairment and people with schizophrenia or bipolar disorder report some improvements in memory, attention and executive function, though trials are small and heterogeneous (Speers et al., 2021).

Blood sugar, lipids and inflammation

Small trials and reviews report modest reductions in fasting glucose, HbA1c and lipids in certain populations, but findings are inconsistent and not strong enough for clinical recommendations.

Other areas

Early-stage trials have looked at fatigue, quality of life in people receiving cancer therapy, rheumatoid arthritis symptoms, menopause symptoms and general well-being. Results are preliminary and should not guide treatment decisions.

Overall quality of the human evidence

The honest summary is that the literature is promising but imperfect:

• Most trials are small and short.
• Many are sponsored by extract suppliers.
• Extracts and doses vary, making pooling difficult.
• Many participants are generally healthy or mildly symptomatic, not severely ill.
• Long-term safety and effectiveness beyond about three months are poorly studied.

---

Evidence Grading by Outcome

The table below is an interpretive summary. It reflects the author's reading of the literature described above and is not an official regulatory classification. Grades: Moderate (multiple RCTs with generally consistent results, but limited by size or bias), Low-to-moderate, Low (few or inconsistent trials), Very low / preclinical only.

Reading this table fairly: the strongest ashwagandha benefits cluster around stress-related outcomes and sleep, and the farther a claim moves from that core, the thinner the evidence becomes.

---

Ashwagandha Dosage Used in Studies

This section reports what researchers used. It is not a personal recommendation, and anyone with a medical condition or taking medication should discuss dosing with a qualified clinician.

Typical research ranges

Common dosing patterns

• 300 mg twice daily of a root extract is one of the most replicated schedules.
• 600 mg once daily has been used in several trials too.
• 240 mg once daily of a highly concentrated extract appears in some hormone and stress studies.

Key points about dose interpretation

1. Match the extract. A dose is only meaningful in relation to the extract tested.
2. Check withanolide content. Doses expressed in milligrams of extract are not interchangeable across products.
3. Duration matters. Most positive trials ran at least eight weeks, and effects on some outcomes only emerged after several weeks.
4. More is not better. Higher doses have not been proven to produce better results, and some adverse events appear dose-related.
5. Long-term data are limited. Typical trial lengths are up to about three months, with a few going longer, so the safety of years of continuous use is not well characterized.

---

Timing and How to Use Ashwagandha

Morning versus evening

There is no single proven best time. Practical patterns include:

• Twice daily (morning and evening) matches many stress trials.
• Evening or bedtime is common when the target is sleep, and sleep trials often used evening dosing.
• Morning may suit people who feel drowsy with evening dosing, though sleepiness varies between individuals.

With or without food

Taking it with meals is a widely used approach, mainly to reduce stomach upset, and a fat-containing meal might help absorption of lipophilic compounds. Controlled data comparing fed and fasted dosing are limited.

Duration and cycling

Trials generally last 8 to 12 weeks. Whether continuous use beyond that remains useful or safe is uncertain. Some practitioners suggest cycling, for example several weeks on followed by a break, but this approach is based on tradition and caution rather than trial evidence. A reasonable approach, if you choose to use it, is to define a purpose, track whether it helps, and reassess after a trial period instead of taking it indefinitely by default.

Starting low

A cautious approach is to begin at a lower dose within the studied range and watch for tolerability before moving up. This is general supplement practice, not a trial-validated protocol.

Tracking your response

Useful practical habits include keeping a simple log of sleep, mood, energy and any symptoms, and stopping and seeking medical advice if you notice yellowing of the skin or eyes, dark urine, pale stools, persistent nausea, abdominal pain, unusual fatigue or itching. These can be signs of liver trouble.

When to stop before procedures

Because the herb may have sedative effects and may interact with anesthetic and other medicines, people scheduled for surgery are generally advised to stop supplements in advance. Follow the instructions of the surgical team, which often suggest stopping at least two weeks beforehand.

---

Available Forms of Ashwagandha

Capsules and tablets

The most common format, usually containing standardized root extract. Look for clear labeling of extract type, withanolide percentage and amount per capsule.

Powders

Traditional root powder can be mixed into milk, smoothies or warm drinks. Taste is earthy and bitter, and potency is typically unstandardized. Doses in grams are not equivalent to extract doses in milligrams.

Liquid extracts and tinctures

Convenient for flexible dosing, but concentration and alcohol content vary, and standardized human data using tinctures are scarce.

Gummies

Popular but often contain lower doses than clinical trials used, plus sugar or sweeteners. Check milligrams per serving and whether the extract is standardized.

Teas and beverages

Typically low in active content. They can be a pleasant ritual but may not deliver trial-level doses.

Branded and proprietary extracts

Branded extracts often come with their own clinical research, which is a benefit when the research is independent and published. Remember that outcomes belong to the specific extract tested.

Combination products

Stress, sleep and sports formulas often combine it with other ingredients. These make it difficult to know what is responsible for any effect and can raise interaction concerns, particularly with sedative blends.

Topical use

Traditional oil preparations exist for external use, but evidence for modern topical products is minimal.

Choosing a form

For people who want to replicate the research, the most straightforward option is a capsule containing a standardized extract at a trial-based dose, with transparent third-party testing.

---

Ashwagandha Safety and Side Effects

General tolerability

In short-term clinical trials, the herb is usually well tolerated, and adverse events are often similar in frequency between active and placebo groups. A systematic review of randomized trials concluded that reported side effects were generally mild, while emphasizing the limited duration and size of the studies (Ng et al., 2020).

Common side effects

Reported effects, usually mild and temporary, include:

• Upset stomach, nausea or diarrhea
• Drowsiness or sedation
• Headache
• Dizziness
• Loose stools or changes in appetite

Liver injury: the key safety signal

Since around 2018, case reports and case series have documented clinically apparent liver injury in people using ashwagandha-containing products, typically within weeks to a few months of starting. A published series from Iceland and the United States described patients with a mainly cholestatic or mixed pattern, with jaundice, itching and markedly raised liver enzymes (Björnsson et al., 2020). Most recovered after stopping the product, though some required hospitalization and rare severe outcomes have been reported. The U.S. National Library of Medicine's LiverTox database classifies the herb as a likely cause of rare, idiosyncratic liver injury.

Important context for interpretation:

• The injury appears rare relative to the number of users, and reports often involve multi-ingredient products.
• Causality is difficult to prove in individual cases, though improvement after stopping and recurrence on rechallenge in some patients supports a link.
• The mechanism is not established. Contaminants, other herbs, product adulteration and individual susceptibility have all been proposed.
• Typical trial protocols often monitored liver enzymes, and most did not find consistent changes, but trials are too small to detect rare events.

Practical advice: anyone with existing liver disease, heavy alcohol use or on liver-affecting drugs should speak to a clinician before use, and anyone who develops symptoms of liver trouble should stop immediately and seek care.

Thyroid effects

Because it can raise thyroid hormone levels in some individuals, people with hyperthyroidism, or taking thyroid hormone replacement, should avoid self-experimenting.

Hormonal and mood considerations

Reports exist of mood changes or emotional blunting in some users, and the herb's effect on hormones means people with hormone-sensitive conditions should seek advice.

Allergy and nightshade sensitivity

As a member of the nightshade family, it may trigger reactions in sensitive individuals, including skin reactions or digestive symptoms.

Long-term safety

Evidence beyond about three months of continuous use is limited. For that reason, indefinite daily use cannot be called proven safe, and periodic reassessment is sensible.

Toxicity of different plant parts

Leaves, with their higher withaferin A content, are generally considered to carry more theoretical toxicity concern than roots at equal dose, which is why leaf-containing products specify limits for this compound.

---

Drug and Supplement Interactions

Interaction data are mostly theoretical or based on case reports and small studies, so caution rather than certainty is the right frame.

Supplement stacks

Combining it with other sedating herbs (valerian, kava, passionflower), melatonin, GABA supplements or high-dose magnesium may intensify drowsiness. Combining it with other herbs known to affect the liver adds a further reason for caution, and kava in particular has its own liver-safety concerns.

What to do

Share a full list of medicines and supplements with a pharmacist or physician before starting, particularly if you take prescription drugs for thyroid, blood sugar, blood pressure, mood or immune conditions.

---

Special Populations

Pregnancy

Traditional texts describe use for pregnancy-related conditions, but modern guidance generally advises avoiding it in pregnancy. Concerns include possible uterine effects and a lack of safety data, and some regulators have cited it as unsuitable for pregnant women. This is a widely held precaution that should be followed.

Breastfeeding

Safety data are insufficient. Avoidance is the cautious position.

Children and adolescents

There are very few pediatric studies, so routine use is not supported. It should not be given to children without medical advice.

Older adults

Some trials have included older adults and reported good tolerability, but older people are more likely to take multiple medicines and to have reduced liver or kidney function, raising interaction and safety questions.

People with liver disease

Given the reported liver-injury signal, people with existing liver conditions are usually advised to avoid it unless a clinician has specifically approved it.

People with thyroid conditions

Both hyperthyroidism and hypothyroidism require medical supervision, as the herb may change hormone levels.

Autoimmune disease

Because of potential immune effects, people with conditions such as rheumatoid arthritis, lupus, multiple sclerosis or Hashimoto's thyroiditis should consult a specialist before use.

Hormone-sensitive conditions

Those with conditions affected by androgens or other hormones, including some cancers, should discuss use with their doctor.

Mental health conditions

Several trials have included people with anxiety or mood disorders, but this is not a replacement for professional care, and anyone on psychiatric medication should seek advice. People with bipolar disorder in particular should be cautious about unsupervised use of any mood-active botanical.

Athletes

Competitive athletes should check whether the product is certified for sport, since contamination with banned substances is a known risk across the supplement industry.

People having surgery

Stop in advance per medical instruction, as described earlier.

---

Quality, Testing and Authentication

Why quality control matters here

The supplement market is not uniform. Studies of botanical products across the industry have found mislabeling, inconsistent potency and contamination. For a herb with a rare but serious safety signal, product quality is not a minor detail.

What good quality looks like

A trustworthy product typically offers:

• Clear identification: botanical name, plant part and extract type on the label.
• Standardization: a stated percentage of withanolides, with the method of analysis.
• Certificate of analysis (COA): batch-specific results available on request.
• Third-party testing or certification: for example by independent organizations that verify identity, potency and contaminants.
• GMP manufacturing: compliance with current good manufacturing practice.
• Transparent origin: supplier and growing region disclosed or traceable.

Authentication methods

Laboratories use several complementary tools:

1. Macroscopic and microscopic examination to confirm plant tissue.
2. HPTLC fingerprinting to compare chemical profiles against a reference standard.
3. HPLC and LC-MS/MS to quantify withanolides and detect marker patterns.
4. DNA barcoding to confirm species and identify substitution.
5. Elemental analysis (ICP-MS) to detect heavy metals.
6. Microbiological testing for total plate count, yeast, mold and pathogens.
7. Pesticide and mycotoxin screening.

Practical tips for consumers

• Prefer products whose extract matches a clinical trial extract.
• Be cautious of exaggerated claims, miracle language and unusually low prices.
• Choose single-ingredient products first, so that any reaction is easier to interpret.
• Check batch numbers and expiry dates, and store products as directed.
• Keep the packaging if you experience side effects, so batch information is available.

---

Adulteration and Contamination Risks

Types of adulteration

Concerns documented across the botanical industry, and relevant to this ingredient, include:

• Substitution with cheaper, related plants or other parts of the plant.
• Dilution with fillers such as starch, rice flour or exhausted extract material.
• Spiking of leaf material or added isolated compounds to inflate marker numbers.
• Undeclared additives in multi-ingredient formulations.
• Mislabeled potency, where actual withanolide content falls well below the label.

Contaminants

• Heavy metals: a well-known concern in some traditional Ayurvedic products. A widely cited study of Ayurvedic medicines sold online found a notable share contained detectable lead, mercury or arsenic (Saper et al., 2008). Although that study covered a range of products and not just this root, it illustrates why metal testing matters, particularly for products made outside strict quality systems.
• Pesticide residues from field cultivation.
• Microbial contamination and mycotoxins, including aflatoxins linked to poor drying and storage.
• Residual solvents in solvent-extracted products.
• Allergens and cross-contamination in shared manufacturing facilities.

Why it may relate to the liver-injury reports

Investigators have raised the possibility that some liver-injury cases involve contaminants, adulterants or other ingredients, rather than the herb itself. At present, the evidence does not settle this question, and so neither dismissing nor over-attributing the signal is justified. Both product quality and individual susceptibility likely matter.

Reducing your risk

Buy from reputable sellers with published testing, avoid unregulated imports of unknown origin, and be wary of "proprietary blends" that hide quantities.

---

Regulatory Overview

Regulatory treatment varies by country and changes over time, so readers should verify current rules with the relevant authority. The overview below is general.

India

The herb is a recognized ingredient in Ayurvedic pharmacopoeias and licensed traditional medicines. The Ministry of AYUSH supports cultivation and standards, and Indian pharmacopoeial monographs describe identity and quality parameters.

United States

It is marketed as a dietary supplement under the framework established by the Dietary Supplement Health and Education Act. Supplements are not approved as drugs, manufacturers are responsible for safety and truthful labeling, and companies cannot claim to treat or cure diseases. The FDA can act on unsafe products after they reach the market, and reports of adverse events can be filed through its reporting system.

European Union

Rules differ between member states, and health claims for botanicals are tightly controlled under the EU claims framework, where most botanical claims remain unauthorized. Some national authorities have taken a restrictive approach to this ingredient. Denmark, for example, has been among the most cautious countries, restricting its use in supplements on safety grounds. Consumers in Europe should check their national authority's current position.

United Kingdom

Sold as a food supplement or traditional herbal product depending on classification, with claims limited by retained claims rules.

Canada

Natural health products containing the root are regulated through a licensing system with monographs that specify permitted uses, dose ranges and required cautions, including warnings for pregnancy and breastfeeding.

Australia

The Therapeutic Goods Administration regulates it as a listed complementary medicine, and has required cautionary labeling on some products relating to liver-related adverse events.

Sports regulation

It is not generally listed as a prohibited substance by the World Anti-Doping Agency, but contamination risk with other supplements means athletes should use certified products.

Regulatory themes

Across regions, three themes recur: (1) regulators allow sales but restrict disease claims, (2) pregnancy and liver-related cautions are increasingly emphasized, and (3) product quality enforcement is uneven. Always check the current guidance from the authority in your country.

---

Research Gaps

Despite two decades of active research, important questions remain unanswered. Identifying them is part of reading the science honestly.

1. Long-term safety. Most trials last under three months. Data on one to several years of continuous use are scarce.
2. Liver injury mechanism and risk factors. We do not know why a small minority of users develop liver injury, whether contaminants play a role, or whether genetic factors or specific preparations raise risk.
3. Standardization across extracts. Without consensus on which compounds and ratios define a clinically relevant extract, comparing trials is difficult.
4. Human pharmacokinetics. Robust human data on absorption, tissue distribution and elimination of key withanolides are limited.
5. Dose-response relationships. Few trials directly compare multiple doses, so the optimal dose for each outcome is unknown.
6. Independent, larger trials. Many studies are small and industry-funded, so large, pre-registered, independent RCTs are needed.
7. Active constituents for specific outcomes. It remains uncertain which components drive sleep, stress or strength effects.
8. Special populations. Pregnancy, children, older adults and people with chronic disease are underrepresented.
9. Drug interactions in humans. Most interaction concerns are theoretical or from case reports.
10. Clinical endpoints. Many trials rely on questionnaires and biomarkers instead of hard clinical outcomes.
11. Hormonal effects. The consistency, clinical relevance and mechanism of effects on testosterone and thyroid hormones are unclear.
12. Placebo and expectancy effects. Stress and sleep outcomes are strongly influenced by expectations, so careful blinding is crucial.
13. Adulteration prevalence. Systematic market surveillance for this specific ingredient is limited.

Future studies that address these gaps would help move several outcomes from low-to-moderate to firmly established, or reveal which popular claims should be dropped.

---

Frequently Asked Questions About Ashwagandha

1. What is ashwagandha used for? It is mainly used to help manage stress and anxiety, support sleep, and, in combination with training, support strength and recovery. Other uses are less well established.

2. How long does it take to work? Most trials report changes after four to eight weeks, with fuller effects over eight to twelve weeks. Some people notice calming effects sooner, but this is variable.

3. What is the best ashwagandha dosage? Studies mostly used 250 to 600 mg per day of a standardized root extract, often 300 mg twice daily. The right amount depends on the extract and the individual, so discuss it with a healthcare professional.

4. Is it safe to take every day? Short-term daily use for up to about three months appears to be well tolerated by most healthy adults in trials, but long-term safety is not established, and rare liver injury has been reported.

5. Can it damage the liver? Rare cases of liver injury have been reported. If you notice yellow skin or eyes, dark urine, pale stools, severe itching or unusual abdominal pain, stop and seek medical care.

6. Does it lower cortisol? Several trials in stressed adults reported lower serum cortisol compared with placebo, although the clinical meaning of this change is still debated.

7. Does it increase testosterone? Some trials reported modest increases in testosterone or DHEA-S, but evidence is limited, and it is not an established treatment for low testosterone.

8. Is it good for sleep? Meta-analytic data suggest a small improvement in sleep quality, especially in people with insomnia and at doses of about 600 mg per day or higher.

9. Can I take it with antidepressants or anxiety medication? Do not combine without medical advice, because additive effects are possible.

10. Is it safe during pregnancy or breastfeeding? It is generally advised to avoid it in both situations.

11. Root or leaf: which is better? Most clinical research uses root extracts, whereas leaves contain more withaferin A and are less well studied. Root-based products are more closely tied to the clinical evidence.

12. Should I take it in the morning or at night? Both patterns appear in research. Evening dosing is common for sleep, and split dosing for stress. Choose a schedule that you can maintain and tolerate.

13. Can I take it with other supplements? Often yes, but combining with sedatives, thyroid-active or liver-affecting products calls for caution and professional advice.

14. How do I choose a good product? Look for a standardized extract matching a studied preparation, a clear certificate of analysis, third-party testing and transparent sourcing.

15. Does it treat cancer or diabetes? No. Laboratory results are intriguing, but there is no proof of treatment benefit in people, and it must never replace prescribed care.

16. Should I stop it before surgery? Generally yes. Tell your surgical team about all supplements, and follow their instructions on when to stop.

17. Is there a call to action for readers? Yes. If you are considering using it, review your health history and medicines with a qualified professional, pick a tested product that matches clinical research, set a clear goal and a time-limited trial, and track how you feel. Use this guide as a starting point and verify key claims in the primary studies listed below.

---

Scientific References

1. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262.
2. Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186.
3. Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of ashwagandha on sleep: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2021;16(9):e0257843.
4. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and safety of ashwagandha root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019;11(9):e5797.
5. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015;12:43.
6. Bonilla DA, Moreno Y, Gho C, Petro JL, Odriozola-Martinez A, Kreider RB. Effects of ashwagandha (Withania somnifera) on physical performance: systematic review and Bayesian meta-analysis. J Funct Morphol Kinesiol. 2021;6(1):20.
7. Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. J Altern Complement Med. 2018;24(3):243-248.
8. Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Clinical evaluation of the spermatogenic activity of the root extract of ashwagandha in oligospermic males. Evid Based Complement Alternat Med. 2013;2013:571420.
9. Dongre S, Langade D, Bhattacharyya S. Efficacy and safety of ashwagandha root extract in improving sexual function in women: a pilot study. Biomed Res Int. 2015;2015:284154.
10. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha. J Altern Complement Med. 2014;20(12):901-908.
11. Speers AB, Cabey KA, Soumyanath A, Wright KM. Effects of Withania somnifera (ashwagandha) on stress and the stress-related neuropsychiatric disorders anxiety, depression, and insomnia. Curr Neuropharmacol. 2021;19(9):1468-1495.
12. Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829.
13. Ng QX, Loke W, Foo NX, Tan WJ, Chan HW, Lim DY, Yeo WS. A systematic review of the clinical use of Withania somnifera (ashwagandha) to ameliorate cognitive dysfunction. Phytother Res. 2020;34(3):583-590. (Cited for general tolerability and clinical-use context.)
14. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera, the Indian ginseng. Cell Mol Life Sci. 2015;72(23):4445-4460.
15. Mikulska P, Malinowska M, Ignacyk M, et al. Ashwagandha (Withania somnifera): current research on the health-promoting activities: a narrative review. Pharmaceutics. 2023;15(4):1057.
16. Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14(7):2373-2393.
17. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-923.
18. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Entry: Ashwagandha. Bethesda (MD): NIDDK; continuously updated.

Medical disclaimer: This article is for general educational purposes and is not medical advice. It does not diagnose, treat or prevent any condition. Consult a qualified healthcare professional before using any supplement, especially if you are pregnant, have a medical condition or take medication. Regulatory positions and research evolve, so verify current information with official sources.